EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology

Eden M Jacob, Jiaoti Huang, Ming Chen

Precision Clinical Medicine · 24.07.2024 · 7 (3)

DOI: 10.1093/pcmedi/pbae017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 01.08.2024. Verfasst von Eden M Jacob und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, Department of Defense Prostate Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The delivery of lipid nanoparticle (LNP)-based mRNA therapeutics has captured the attention of the vaccine research community as an innovative and versatile tool for treating a variety of human malignancies. mRNA vaccines are now in the limelight as an alternative to conventional vaccines owing to their high precision, low-cost, rapid manufacture, and superior safety profile. Multiple mRNA vaccine platforms have been developed to target several types of cancer, and many have demonstrated encouraging results in animal models and human trials. The effectiveness of these new mRNA vaccines depends on the efficacy and stability of the antigen(s) of interest generated and the reliability of their delivery to antigen-presenting cells (APCs), especially dendritic cells (DCs). In this review, we provide a detailed overview of mRNA vaccines and their delivery strategies and consider future directions and challenges in advancing and expanding this promising vaccine platform to widespread therapeutic use against cancer.

Schlagwörter

Stichwörter der Autor:innen

cancerlipid nanoparticlesmRNA vaccines

Autor:innen und Institutionen

  • Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA.
  • Duke Cancer Institute, Duke University, Durham, NC 27710, USA.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • Department of Defense Prostate Cancer Research Program

Zitieren

APA

Jacob, E. M., Huang, J., & Chen, M. (2024). Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology. Precision Clinical Medicine, 7(3). https://doi.org/10.1093/pcmedi/pbae017

Vancouver

Jacob EM, Huang J, Chen M. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology. Precision Clinical Medicine. 2024;7(3). doi:10.1093/pcmedi/pbae017

BibTeX
@article{Jacob2024,
  author = {Jacob, Eden M and Huang, Jiaoti and Chen, Ming},
  title = {Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology},
  journal = {Precision Clinical Medicine},
  year = {2024},
  volume = {7},
  number = {3},
  doi = {10.1093/pcmedi/pbae017}
}
Kostenlos starten →